- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Nanophase Technologies (Nasdaq: NANX), a leader in nanomaterials and advanced nanoengineered products, announced that for the quarter ending June 30, 2008, the Company achieved total revenue of $2.94 million, compared to $4.1 million in the second quarter of 2007, and grew gross margin as a percentage of revenue to 38%. Nanophase reported a net loss of $788,000, or $0.04/share, for the quarter compared to $241,000, or $0.01/share, in the second quarter of 2007.
"In an increasingly challenging economic and cost environment and considering the inventory stocking that occurred in the second quarter of 2007, Nanophase delivered a relatively solid quarter," stated Joseph Cross, Nanophase's president and CEO. "The quarter was as forecast, essentially flat to the first quarter. We knew that the second quarter of 2007 benefitted from architectural coating orders for retail rollout and inventory-building with our market partner, BYK Chemie, amounting to $1.2 million more revenue in that quarter than the current second quarter."
For the first half of 2008, Nanophase revenues were $6.0 million, compared with $7 million in the first half of 2007. Gross margin was 36%, a 4% increase over the same period in 2007. The net loss was $1.7 million, or $0.08/share, compared to $1.5 million, or $0.08/share, in the first half of 2007.
Cross noted, "Gross margin growth, along with cost control management, has reduced the Company's cash used for operations to an average of $350,000 per quarter, a reduction of 57% from the same period in 2007. Exiting the first half, Nanophase has $15.8 million in cash and investments and, we believe, is adequately funded for the future."
Markets and Outlook
Cross noted that the Company continues to make sound progress adding new opportunities and moving those through the stage gate sales process toward revenue producing applications. In the second quarter the Company added three new customers for glass polishing, electrostatic discharge protection, and animal hygiene. Nanophase is pursuing opportunities in chemical mechanical polishing for semiconductors, energy, architectural coatings, natural rubber latex products, SPF clothing, industrial coatings, and several other markets.
"We have added sales personnel, realigned R&D and internal resources with our business development opportunities and are seeing increased success in new product development as evidenced by the three new customers we have noted," stated Cross. "We believe that we are taking the proper actions to identify new markets and capture new sales and we remain optimistic going forward."
"Relative to the second half of the year, we have recently become aware of over-inventory conditions at both BASF and BYK Chemie that will likely effect their order requirements. While we expect this to be a one to two quarter situation until the inventory is reduced, it will impact our previous revenue expectations for the second half of 2008. It also seems apparent that economic conditions may restrict existing business growth and new business volumes. We now believe that third and fourth quarter will be relatively flat compared with our second quarter. As such, it now appears that total 2008 revenue will be down about 10-15% year-over-year."
Nanophase has scheduled its quarterly conference call for July 22 at 4:00 PM CDT, 5:00 PM EDT, which will be hosted by Joseph Cross, president and CEO, and Jess Jankowski, CFO. The call may be accessed through the Company's website, www.nanophase.com, by clicking on the link under Investor Relations and Calendar of Events. If you are unable to attend, a replay will be available through July 29, 2008 by dialing 706-645-9291 and entering code 55557439, or by logging onto the Company's website and following the above directions.
About Nanophase Technologies
Nanophase Technologies Corporation (NANX), www.nanophase.com, is a leader in nanomaterials technologies and provides nanoengineered solutions for multiple industrial product applications. Using a platform of patented and proprietary integrated nanomaterial technologies, the Company creates products with unique performance attributes from two ISO 9001:2000 and ISO 14001 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media. The Company owns or licenses 18 United States and 49 foreign patents and patent applications. Information about Nanophase may be found in the Company’s public filings or on its website.
All numbers in this release are approximate; refer to the financials accompanying the release for details. Earnings per share are stated as fully diluted. This press release contains words such as "expects", "shall", "will", "believes" and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company’s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company’s results of operations, performance and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risk and uncertainties include the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company’s dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company’s nanocrystalline materials; the Company’s manufacturing capacity and product mix flexibility in light of customer demand; the Company’s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company’s dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; and other risks described in the Company’s Form 10K filed March 14, 2008, and other filings with the Securities and Exchange Commission. In addition, the Company’s forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.
NANOPHASE TECHNOLOGIES CORPORATION BALANCE SHEETS (Unaudited) June 30, December 31, ASSETS 2008 2007 Current assets: Cash and cash equivalents $908,493 $563,075 Investments 8,881,386 16,145,844 Trade accounts receivable, less allowance for doubtful accounts of $13,000 on June 30, 2008 and December 31, 2007 1,289,652 1,403,206 Inventories, net 1,571,760 1,085,364 Prepaid expenses and other current assets 427,601 298,464 Total current assets 13,078,892 19,495,953 Investments 6,000,000 - Equipment and leasehold improvements, net 7,085,963 7,409,666 Other assets, net 627,685 781,266 $26,792,540 $27,686,885 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Current portion of deferred other revenue 127,273 127,273 Current portion of capital lease obligations 40,300 43,110 Accounts payable 617,709 238,295 Accrued expenses 1,640,446 1,584,656 Total current liabilities 2,425,728 1,993,334 Long-term debt, less current maturities and unamortized debt discount 1,540,703 1,512,507 Long-term portion of capital lease obligations 13,170 31,430 Deferred other revenue, less current portion 10,609 74,243 1,564,482 1,618,180 Contingent liabilities: - - Stockholders’ equity: Preferred stock, $.01 par value, 24,088 shares authorized and no shares issued and outstanding - - Common stock, $.01 par value, 30,000,000 shares authorized; 21,130,697 and 21,088,068 shares issued and outstanding on June 30, 2008 and December 31, 2007, respectively 211,307 210,881 Additional paid-in capital 90,663,474 90,201,131 Accumulated deficit (68,072,451) (66,336,641) Total stockholders’ equity 22,802,330 24,075,371 $26,792,540 $27,686,885 NANOPHASE TECHNOLOGIES CORPORATION STATEMENTS OF OPERATIONS (Unaudited) Three months ended Six months ended June 30, June 30, 2008 2007 2008 2007 Revenue: Product revenue, net $2,811,626 $4,015,275 $5,754,347 $6,809,416 Other revenue 132,780 110,233 244,167 222,529 Total revenue 2,944,406 4,125,508 5,998,514 7,031,945 Operating expense: Cost of revenue 1,836,276 2,611,249 3,836,484 4,804,524 Gross Profit 1,108,130 1,514,259 2,162,030 2,227,421 Research and development expense 416,239 450,005 854,934 974,169 Selling, general and administrative expense 1,525,446 1,360,957 3,219,514 2,771,217 Loss from operations (833,555) (296,703) (1,912,418) (1,517,965) Interest income 80,788 89,202 248,010 188,829 Interest expense (33,142) (34,173) (71,559) (67,220) Other, net (2,074) 248 157 (69,097) Loss before provision for income taxes (787,983) (241,426) (1,735,810) (1,465,453) Provision for income taxes - - - - Net loss $(787,983) $(241,426) $(1,735,810) $(1,465,453) Net loss per share -- basic and diluted $(0.04) $(0.01) $(0.08) $(0.08) Weighted average number of common shares outstanding 21,130,697 19,070,236 21,118,652 19,038,217 NANOPHASE TECHNOLOGIES CORPORATION STATEMENTS OF OPERATIONS - EXPANDED SCHEDULE (Unaudited) Three months ended Six months ended June 30, June 30, 2008 2007 2008 2007 Revenue: Product revenue, net $2,811,626 $4,015,275 $5,754,347 $6,809,416 Other revenue 132,780 110,233 244,167 222,529 Total revenue 2,944,406 4,125,508 5,998,514 7,031,945 Operating expense: Cost of revenue detail: Depreciation 240,575 278,052 478,620 558,133 Non-Cash equity compensation 20,165 13,488 36,936 27,889 Other costs of revenue 1,575,536 2,319,709 3,320,928 4,218,502 Cost of revenue 1,836,276 2,611,249 3,836,484 4,804,524 Gross profit 1,108,130 1,514,259 2,162,030 2,227,421 Research and development expense detail: Depreciation 59,318 58,612 117,775 113,974 Non-Cash equity compensation 38,281 16,736 69,313 61,966 Other research and development expense 318,640 374,657 667,846 798,229 Research and development expense 416,239 450,005 854,934 974,169 Selling, general and administrative expense detail: Depreciation and amortization 24,509 19,727 48,603 38,824 Non-Cash equity compensation 173,682 79,218 326,634 225,923 Other selling, general and administrative expense 1,327,255 1,262,012 2,844,277 2,506,470 Selling, general and administrative expense 1,525,446 1,360,957 3,219,514 2,771,217 Loss from operations (833,555) (296,703) (1,912,418) (1,517,965) Interest income 80,788 89,202 248,010 188,829 Interest expense (33,142) (34,173) (71,559) (67,220) Other, net (2,074) 248 157 (69,097) Loss before provision for income taxes (787,983) (241,426) (1,735,810) (1,465,453) Provision for income taxes - - - - Net loss $(787,983) $(241,426) $(1,735,810) $(1,465,453)
For more information, please click here
Nanophase Technologies Corporation
1319 Marquette Drive
Romeoville, IL 60446
Copyright © PR Newswire Association LLC.If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Electron spin brings order to high entropy alloys April 23rd, 2015
Arrowhead to Report Fiscal 2015 First Quarter Financial Results February 2nd, 2015
Graphenea sales more than double in 2014 January 29th, 2015
Richards-Kortum elected to American Academy of Arts and Sciences: April 22nd, 2015
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015